查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948979

整形外科义肢市场（材料类型、应用、产品类型和最终用户划分），全球预测（2026-2032）

Orthopedic Forged Protheses Market by Material Type, Application, Product Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年整形外科锻造关节假体市值为63.4亿美元，预计2026年将成长至68.9亿美元，年复合成长率为9.58%，到2032年将达到120.4亿美元。

关键市场统计数据
基准年 2025 63.4亿美元
预计年份：2026年 68.9亿美元
预测年份 2032 120.4亿美元
复合年增长率 (%) 9.58%

这是一份简明的策略指南，整合了临床、製造和供应趋势，为整形外科矫形人工替代物领域的商业决策提供支援。

整形外科骨科人工替代物领域正处于外科创新、材料科学和复杂供应链动态的关键交汇点。冶金、精密製造和植入设计方面的进步，使得临床需求与商业性需求趋于一致：外科医生要求器械具备持久的动态性能和生物相容性，采购机构优先考虑可靠的供应来源和成本控制，而製造商则面临着在扩大生产规模的同时，保持产品质量可重复性的压力。

材料创新、数位化手术整合、日益严格的监管以及供应链韧性将重新定义植入製造领域的竞争优势。

整形外科矫形人工替代物领域正经历变革，这主要归因于技术、临床和监管三方压力的共同作用。材料加工技术的快速发展以及积层製造带来的精加工技术进步，使得植入能够实现更严格的公差和更精细的表面处理，从而显着提升骨整合性能和长期耐久性。同时，数位化手术规划和术中导航技术不断提高植入几何形状和器械相容性方面的性能标准，这就要求器械设计者和软体供应商之间进行更紧密的合作。

分析新近生效的美国关税及其对企业营运、采购和临床等方面的多方面影响。

2025年美国关税对整形外科锻造人工替代物系统的采购、製造策略和竞争地位产生了多方面的影响。关税带来的成本压力迫使製造商和经销商重新评估其关键原材料和成品组件的筹资策略，许多企业开展短期成本转嫁分析和长期供应商重组计划，以维持利润率和市场进入。

将材料科学、外科应用、产品系列、临床环境和分销模式与策略性製造和商业选择联繫起来的详细細項分析

了解细分市场的细微差别对于掌握临床需求、采购行为和製造能力之间的交集至关重要。本研究从材料维度检验了钴铬合金、不銹钢和钛合金。每种材料都有不同的机械性能和生物相容性，这些都会影响植入的选择和製造过程设计。钴铬合金常用于需要高耐磨性的承重关节。不銹钢在某些创伤固定应用中仍然是一种经济有效的选择。当强度重量比和骨整合至关重要时，钛合金是首选。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势将影响采购重点、监管方式和製造地决策。

区域趋势正在塑造竞争格​​局和业务重点，美洲、欧洲、中东和非洲以及亚太地区各有其独特的驱动因素。在美洲，需求与不断变化的医保报销结构以及大型医疗系统在生命週期价值和供应安全方面的整合密切相关。该地区的采购週期通常奖励已证实有效的临床结果和服务可靠性，这为能够展示全面临床数据包和强大物流能力的製造商创造了机会。

透过冶金创新、垂直整合和一体化商业化模式，策略能力和营运选择使领先製造商脱颖而出。

在整形外科锻造关节假体领域，主要企业凭藉研发投入、卓越製造流程和商业性化能力的差异化组合脱颖而出。领先的製造商致力于冶金工艺、表面处理和模组化结构方面的创新，以满足动态和外科医生的工作流程需求。这些投入通常辅以有针对性的临床倡议，旨在支持有关植入耐久性、降低再次手术风险和改善患者报告结果等方面的说法。

在整形外科植入建立永续竞争优势的优先事项：增强供应链韧性、扩大临床证据、推广模组化设计以及优化商业模式

对于希望将洞察转化为可衡量优势的产业领导者而言，一系列切实可行的建议为短期和中期工作提供了切实可行的蓝图。首先，应审查原物料采购情况，并建立伙伴关係以实现供应来源多元化，从而降低关税和地缘政治动盪带来的风险。建立双重采购安排并建构区域生产能力，可以显着提高大宗采购合约的可靠性，并降低到岸成本波动的风险。

结合从业者访谈、技术文献综述、法规梳理和交叉检验分析的混合研究途径，确保了研究结果具有可靠的实务意义。

本分析的调查方法融合了定性专家意见、严谨的二手研究以及同行检验的证据，以确保得出切实可行的循证结论。主要研究包括对经验丰富的骨科医生、医院采购人员、生产企业高管和分销合作伙伴进行结构化访谈，以了解真实的临床偏好、采购决策依据和营运限制。这些从业人员的观点被综合起来，用于识别驱动产品选择的临床优先事项、手术趋势和采购行为。

对整形外科植入领域技术创新、监管和采购趋势以及持续保持领先地位的战略要务进行综合概述

总而言之，整形外科矫形人工替代物的市场格局正受到材料和製造技术创新、监管审查力度加大、采购重点转变以及影响供应链设计的区域政策演变等因素的重塑。这些因素凸显了严谨的临床证据、灵活的製造地以及针对医院、门诊中心和专科诊所独特需求量身定制的商业模式的重要性。那些能够成功平衡冶金性能和设计差异化投资与确保业务永续营运的企业，将更有能力满足临床医生的期望和医疗服务提供者的采购需求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依材料类型整形外科锻造义肢市场

  • 钴铬合金
  • 不銹钢
  • 钛合金

第九章整形外科锻造义肢市场：依应用领域划分

  • 第一次手术
  • 重新置换手术
    • 重新置换
    • 膝关节翻修重新置换
    • 肩关节重新置换术

第十章 按产品类型分類的整形外科锻造义肢市场

  • 足关节移植
  • 髋关节植入
  • 膝关节移植
  • 肩关节关节移植
  • 脊椎移植
    • 笼子和垫片
    • 棒材和板材
    • 螺丝和固定装置
  • 创伤固定

第十一章 依最终用户分類的整形外科锻造义肢市场

  • 门诊手术中心
  • 医院
  • 专业整形外科中心

第十二章整形外科锻造义肢市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章整形外科锻造义肢市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国整形外科锻造义肢市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国整形外科义肢市场

第十六章 中国整形外科锻造义肢市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ace Osteomedica Pvt. Ltd.
  • Capsur Enterprises Pvt. Ltd.
  • DePuy Synthes
  • Globus Medical, Inc.
  • GPC Medical Ltd.
  • Mars Orthopaedic Pvt. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Narang Medical Limited
  • NRV OrthoTech Pvt. Ltd.
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Ottobock SE & Co. KGaA
  • RD Forge
  • Sharma Orthopedic（India）Pvt. Ltd.
  • Simplex Orthopaedic Pvt. Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-4F7A6D4FB921

The Orthopedic Forged Protheses Market was valued at USD 6.34 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, with a CAGR of 9.58%, reaching USD 12.04 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.34 billion
Estimated Year [2026] USD 6.89 billion
Forecast Year [2032] USD 12.04 billion
CAGR (%) 9.58%

A concise strategic orientation that synthesizes clinical, manufacturing, and supply dynamics to inform executive decisions in orthopedic forged prostheses

The evolving field of orthopedic forged prostheses occupies a critical intersection of surgical innovation, materials science, and complex supply chain dynamics. Advances in metallurgy, precision manufacturing, and implant design have created an environment in which clinical expectations and commercial imperatives are converging. Surgeons demand devices that offer durable biomechanics and biological compatibility, procurement organizations prioritize reliable sources and cost containment, and manufacturers face mounting pressure to demonstrate reproducible quality while scaling production.

Against that backdrop, this executive summary synthesizes the most consequential shifts and practical implications for stakeholders across the ecosystem. It underscores where technical breakthroughs are making real differences in clinical outcomes, highlights structural forces reshaping procurement and distribution, and frames priority actions for those seeking to maintain competitive advantage. The aim is to present a concise, evidence-based roadmap that helps executives translate technical detail into investment, manufacturing, and commercial choices.

Readers will find analysis that balances clinical relevance with operational reality, articulating how product-level differentiation, regulatory trajectories, and channel strategies intersect to determine market movement. The result is a high-resolution foundation for strategic planning that supports confident decision-making in a market where precision, reliability, and responsiveness define success.

How material innovation, digital surgical integration, regulatory rigor, and supply chain resilience are redefining competitive advantage in implant manufacturing

The landscape for orthopedic forged prostheses is undergoing transformative shifts driven by converging technological, clinical, and regulatory pressures. Rapid advances in material processing and additive-enabled finishing techniques are enabling implants with tighter tolerances and enhanced surface engineering, which in turn influence osseointegration performance and long-term durability. Concurrently, digital surgical planning and intraoperative navigation technologies are raising the performance bar for implant geometries and instrumentation compatibility, demanding closer collaboration between device designers and software providers.

At the same time, supply chain resilience has become a strategic priority, prompting manufacturers to diversify sourcing for raw alloys and to reassess geographically concentrated production footprints. Regulatory frameworks are growing more exacting with respect to traceability, post-market surveillance, and evidence of clinical effectiveness, obliging firms to expand their clinical data programs and quality management investments. Payer and provider procurement behaviors are also evolving; hospitals and ambulatory centers increasingly base procurement on lifecycle cost, service agreements, and evidence of reduced revision rates rather than simple unit price.

These shifts collectively favor manufacturers who can integrate advanced materials expertise with robust clinical validation, agile supply chain management, and digitally enabled product ecosystems. Companies that align R&D, clinical strategy, and commercialization to these structural changes will be better positioned to capture long-term clinical trust and procurement preference as the category continues to mature.

Analyzing the multidimensional operational, procurement, and clinical consequences of newly enacted United States tariffs and how firms are responding

The implementation of United States tariffs in 2025 has created multi-dimensional effects across procurement, manufacturing strategy, and competitive positioning within the orthopedic forged prostheses ecosystem. Tariff-induced cost pressures have required manufacturers and distributors to reassess sourcing strategies for critical raw inputs and finished assemblies, with many organizations conducting near-term cost pass-through analyses and longer-term supplier reconfiguration plans to preserve margin and market access.

Operationally, the tariffs have accelerated discussions around regional manufacturing capacity and localization. Firms that already maintain or can quickly stand up North American processing capabilities have found themselves with a distinct advantage in satisfying hospital purchasing groups that prioritize predictable total landed cost and supply continuity. Simultaneously, original equipment manufacturers have expanded contractual dialogues around risk-sharing with suppliers and customers, introducing service-level agreements and inventory strategies designed to buffer demand volatility tied to tariff fluctuations.

Clinically, payers and procurement committees are scrutinizing value propositions more closely, linking device selection to lifecycle outcomes and potential downstream costs such as revision procedures. This shift intensifies the importance of robust clinical evidence and post-market surveillance programs as differentiators. From a competitive perspective, the tariff environment has opened windows for vertically integrated producers and regional contract manufacturers to increase their relevance to health systems seeking stable supply flows. Firms that can demonstrate transparent cost structures, diversified supply lines, and validated clinical performance will be in the best position to preserve market access and sustain relationships with large institutional buyers.

Deep segmentation analysis linking material science, surgical application, product families, care settings, and distribution modes to strategic manufacturing and commercial choices

A nuanced understanding of segmentation is essential for capturing where clinical need, procurement behavior, and manufacturing capability intersect. The material dimension of the market is examined across cobalt chromium alloy, stainless steel, and titanium alloy, each offering distinct mechanical properties and biocompatibility profiles that influence implant selection and manufacturing process design. Cobalt chromium alloys often serve load-bearing articulations that require high wear resistance, stainless steel continues to be a cost-effective option in certain trauma fixation applications, and titanium alloys are favored where strength-to-weight ratio and osseointegration are critical.

Application-level distinctions separate primary surgery from revision surgery, with revision procedures further examined across hip, knee, and shoulder contexts. Revision surgeries present heightened technical complexity, demand for modularity, and often necessitate tailored inventory strategies due to variability in bone loss and soft-tissue conditions. Product-level segmentation encompasses foot and ankle implant, hip implant, knee implant, shoulder implant, spine implant, and trauma fixation. The foot and ankle category is further differentiated by ankle fusion devices, ligament reconstruction devices, and total ankle replacement products. Hip implant variations include hemiarthroplasty, revision hip replacement, and total hip replacement, while knee implant distinctions cover partial knee replacement, revision knee replacement, and total knee replacement. Shoulder implants are analyzed across partial shoulder replacement, reverse shoulder replacement, and total shoulder replacement. Spine implant analysis spans cages and spacers, rods and plates, and screws and fixation devices. Trauma fixation is disaggregated into external fixators, intramedullary nails, and plates and screws, reflecting the variety of mechanical and logistical requirements across traumatic indications.

End-user segmentation focuses on ambulatory surgical centers, hospitals, and specialty orthopedic centers, each of which carries different purchasing dynamics, procedural volumes, and instrumentation preferences. Distribution channel analysis compares direct sales relationships with distributor sales models, highlighting differences in account control, aftermarket service expectations, and commercial scalability. Taken together, these segmentation lenses enable precise prioritization of clinical investments, manufacturing capabilities, and commercial approaches tailored to specific product families and care settings.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine procurement priorities, regulatory approaches, and manufacturing footprint decisions

Regional dynamics shape both competitive landscapes and operational priorities, with distinct drivers in the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, demand is closely tied to evolving reimbursement structures and the consolidation of large health systems that negotiate on lifecycle value and supply stability. Procurement cycles in this region often reward proven clinical outcomes and service reliability, creating opportunities for manufacturers who can demonstrate comprehensive clinical data packages and strong logistical performance.

The Europe Middle East & Africa region presents a heterogeneous regulatory and reimbursement environment. Within this geography, national procurement practices and regulatory pathways vary widely, compelling manufacturers to adopt adaptable market entry strategies that balance centralized clinical evidence with localized commercial and regulatory engagement. Cost-containment pressures coexist with a high emphasis on clinical efficacy, making strategic partnerships with regional distributors and clinical centers valuable for navigating varied hospital tender processes and regulatory expectations.

Asia-Pacific is characterized by rapid infrastructure expansion, growing elective procedure volumes, and a dynamic mix of domestic and international manufacturers. Markets within this region are increasingly prioritizing localization, technology transfer, and capacity building, while surgeons and hospitals seek implants that align with both global clinical standards and region-specific anatomical or surgical preferences. Across all regions, geopolitical considerations and supply chain resilience continue to affect sourcing decisions, making regional manufacturing footprint and near-term contingency planning important components of competitive strategy.

Strategic capabilities and operational choices that differentiate leading manufacturers through metallurgical innovation, vertical integration, and integrated commercialization models

Key companies operating in the orthopedic forged prostheses segment are distinguishing themselves through differentiated combinations of R&D focus, manufacturing excellence, and commercial reach. Leading manufacturers are investing to advance metallurgical processes, surface treatments, and modular architectures that address both biomechanics and surgeon workflow preferences. These investments are often complemented by targeted clinical initiatives designed to substantiate claims around implant longevity, reduced revision risk, and improved patient-reported outcomes.

On the operational side, successful firms are increasingly integrating vertical capabilities that enhance control over critical raw materials and forging processes while establishing robust quality systems and traceability protocols. This integration improves responsiveness to demand variability and supports stronger supplier relationships. Commercially, companies that pair strong clinical evidence with flexible channel strategies-balancing direct sales models in high-touch hospital accounts with distributor partnerships in fragmented geographies-tend to capture broader adoption across diverse end-user types.

Strategic collaborations are also prominent, with alliances between device manufacturers and surgical technology providers enabling more holistic offerings that combine implants with digital planning, instrumentation, and services. Additionally, companies that prioritize sustainable manufacturing practices and transparent supply chains are gaining favor among institutional buyers focused on long-term procurement risk mitigation. Taken together, these approaches form a pragmatic blueprint for firms seeking to strengthen market position through technical differentiation, operational resilience, and customer-centric commercialization.

Priority actions to strengthen supply resilience, clinical evidence, modular design, and commercial models for sustained competitive advantage in orthopedic implants

For industry leaders aiming to convert insight into measurable advantage, a set of actionable recommendations provides a practical roadmap for near- and medium-term initiatives. Begin by re-evaluating raw material sourcing and forging partnerships to increase supply diversity and reduce exposure to tariff or geopolitical disruptions. Establishing dual-source arrangements or regional production capacity can materially improve reliability for high-volume institutional contracts and mitigate landed-cost volatility.

Second, accelerate investments in clinical evidence generation that directly align with payer and procurement value criteria. Prioritize post-market surveillance, registries, and targeted outcomes studies that demonstrate reductions in revision rates, reduced downstream costs, or faster patient recovery. These data assets not only support procurement conversations but also strengthen regulatory dossiers and physician adoption.

Third, cultivate differentiated product architectures that respond to both primary and revision surgery complexities. Modular designs, adaptable instrumentation, and a focus on material selection that optimizes osseointegration and wear resistance will resonate with surgeons and purchasing committees. Simultaneously, refine commercial models by combining direct account management for high-value customers with distributor-enabled reach in more fragmented markets, ensuring consistent clinical support and service levels.

Finally, institutionalize agility through scenario planning and cross-functional governance that connects commercial, regulatory, and manufacturing teams. Regularly simulate pricing, tariff, and supply shocks to stress-test inventory strategies and contractual protections. By implementing these recommendations, organizations can more effectively manage risk, differentiate clinically, and capitalize on evolving procurement preferences across care settings.

A mixed-methods research approach combining practitioner interviews, technical literature review, regulatory mapping, and cross-validated analysis to ensure robust, actionable insights

The research methodology underpinning this analysis blends qualitative expert input with rigorous secondary research and cross-validated evidence to ensure that insights are actionable and grounded. Primary research included structured interviews with experienced orthopedic surgeons, hospital procurement leaders, manufacturing executives, and distributor partners to capture real-world clinical preferences, purchasing rationales, and operational constraints. These practitioner perspectives were synthesized to identify clinical priorities, surgical trends, and procurement behaviors that drive product selection.

Complementing primary input, secondary research drew on technical literature, regulatory filings, and company disclosures to map material properties, manufacturing practices, and documented clinical outcomes. Where appropriate, device design characteristics and instrumentation requirements were compared against published clinical studies and regulatory summaries to validate claims around performance and safety. Data triangulation and iterative validation sessions with subject-matter experts were used to reconcile divergent perspectives and refine segmentation boundaries.

Analytical procedures included qualitative thematic coding of interview transcripts, cross-regional comparison of regulatory and procurement frameworks, and scenario analysis to evaluate the operational impact of tariffs and supply chain shifts. Quality assurance steps consisted of independent review by domain experts, consistency checks across evidence streams, and a documented audit trail for each major conclusion. This mixed-methods approach ensures that the insights presented are both empirically grounded and practically relevant to executive decision-making.

Concluding synthesis that integrates technical innovation, regulatory and procurement dynamics, and strategic imperatives for sustained leadership in orthopedic implants

In summary, the orthopedic forged prostheses landscape is being reshaped by material and manufacturing innovation, heightened regulatory scrutiny, shifting procurement priorities, and regional policy developments that influence supply chain design. These forces are elevating the importance of rigorous clinical evidence, flexible manufacturing footprints, and commercial models that align with the distinct needs of hospitals, ambulatory centers, and specialty providers. Organizations that balance investment in metallurgical and design differentiation with operational resilience will be better positioned to meet clinician expectations and institutional procurement demands.

Tariff-driven cost pressures and geopolitical uncertainty reinforce the need for deliberate supplier diversification and transparent cost structures, while modular product strategies and targeted clinical programs can drive adoption across both primary and increasingly complex revision surgeries. Regional variation requires tailored approaches; success depends on the ability to localize where necessary and to build partnerships that bridge regulatory and procurement nuances.

Ultimately, the companies that successfully integrate technical excellence, validated clinical outcomes, and agile commercial strategies will capture enduring preference among surgeons and health systems. This executive summary serves as a strategic compass for leaders looking to prioritize investments, refine supply models, and accelerate clinically driven adoption in a market where reliability and evidence are the primary currencies of decision-making.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Orthopedic Forged Protheses Market, by Material Type

  • 8.1. Cobalt Chromium Alloy
  • 8.2. Stainless Steel
  • 8.3. Titanium Alloy

9. Orthopedic Forged Protheses Market, by Application

  • 9.1. Primary Surgery
  • 9.2. Revision Surgery
    • 9.2.1. Hip Revision
    • 9.2.2. Knee Revision
    • 9.2.3. Shoulder Revision

10. Orthopedic Forged Protheses Market, by Product Type

  • 10.1. Foot And Ankle Implant
  • 10.2. Hip Implant
  • 10.3. Knee Implant
  • 10.4. Shoulder Implant
  • 10.5. Spine Implant
    • 10.5.1. Cages & Spacers
    • 10.5.2. Rods & Plates
    • 10.5.3. Screws & Fixation Devices
  • 10.6. Trauma Fixation

11. Orthopedic Forged Protheses Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospital
  • 11.3. Specialty Orthopedic Center

12. Orthopedic Forged Protheses Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Orthopedic Forged Protheses Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Orthopedic Forged Protheses Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Orthopedic Forged Protheses Market

16. China Orthopedic Forged Protheses Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ace Osteomedica Pvt. Ltd.
  • 17.6. Capsur Enterprises Pvt. Ltd.
  • 17.7. DePuy Synthes
  • 17.8. Globus Medical, Inc.
  • 17.9. GPC Medical Ltd.
  • 17.10. Mars Orthopaedic Pvt. Ltd.
  • 17.11. Medtronic plc
  • 17.12. Meril Life Sciences Pvt. Ltd.
  • 17.13. Narang Medical Limited
  • 17.14. NRV OrthoTech Pvt. Ltd.
  • 17.15. NuVasive, Inc.
  • 17.16. Orthofix Medical Inc.
  • 17.17. Ottobock SE & Co. KGaA
  • 17.18. R D Forge
  • 17.19. Sharma Orthopedic (India) Pvt. Ltd.
  • 17.20. Simplex Orthopaedic Pvt. Ltd.
  • 17.21. Smith & Nephew plc
  • 17.22. Stryker Corporation
  • 17.23. Zimmer Biomet Holdings, Inc.
  • 17.24. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)